The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on March 31, 2021 to holders of record on March 10,...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the publication of a peer-reviewed study that shows BD's antigen test may be more...
Perhaps during a routine screening, you or your doctor found a lump; perhaps you’re experiencing some kind of pain in your breast. If a mammogram or exam requires a closer look, your doctor may...
Rob Suárez, VP, Chief Information Security Officer for BD In recent months, the healthcare industry has seen an unprecedented increase in cyberattacks, from threat actors masquerading as trusted...
Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health. This is how we make a difference in human health across generations. This is our work and this is our passion.
The BD Innovation and Engagement Center in Eysins Switzerland offers visiting healthcare professionals a collaborative and immersive environment to grasp the full scope of BD solutions to healthcare challenges across the care continuum.
